Stock Based Compensation (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 14, 2020 |
Jun. 04, 2019 |
May 14, 2019 |
Jul. 08, 2020 |
Jun. 15, 2020 |
Dec. 20, 2019 |
Jun. 28, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2019 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Stock based compensation | $ 369,427 | $ 0 | $ 1,762,736 | $ 1,710,226 | $ 1,810,267 | |||||||
| Extension of certain stock option expiration | $ 745,989 | |||||||||||
| Nonqualified Stock Options[Member] | ||||||||||||
| Exercise price | $ 0.19 | $ 0.25 | $ 0.27 | |||||||||
| Common stock shares issued for services | 250,000 | 100,000 | 4,600,000 | |||||||||
| Debt conversion description | The options granted are exercisable at $0.19 per share, representing the fair market value of the common stock on the date of grant as determined under the 2017 Plan. Fifty percent of the options are fully vested and exercisable as of the date of grant and fifty percent of the options vest on April 1, 2021 | The options granted are exercisable at $0.25 per share, representing the fair market value of the common stock on the date of grant as determined under the 2017 Equity Plan. The options are fully vested and exercisable as of the date of grant and will expire five years thereafter | The options granted are exercisable at $0.27 per share, representing the fair market value of the common stock on the date of grant as determined under the 2017 Equity Plan. The options are fully vested and exercisable as of the date of grant and will expire five years thereafter. | |||||||||
| Stock Issued During Period, Value | $ 37,882 | $ 18,723 | $ 898,207 | |||||||||
| Board of Directors [Member] | ||||||||||||
| Exercise price | $ 0.58 | $ 0.19 | ||||||||||
| General and administrative expenses | $ 884,264 | $ 246,965 | ||||||||||
| Vested and exercisable expire | 5 years | 5 years | ||||||||||
| Stock options descripton | The Company granted nonqualified stock options to the following executive officers to each acquire 500,000 shares of the Company’s common stock: Richard MacPherson (President and Chief Executive Officer), John Pavlish (Senior Vice President and Chief Technology Officer) and James Trettel (Vice President of Operations); and, also granted nonqualified stock options to the following persons to each acquire 250,000 shares of the Company’s common stock: Christopher Greenberg (Chairman of the Board) and David M. Kaye (director); and, also granted nonqualified stock options to the following persons to acquire 125,000 and 50,000, respectively | The Company approved an amendment to the 2017 Plan to increase the maximum number of shares of common stock that may be issued under the 2017 Plan from 8,000,000 to 12,000,000 shares. On the same date, the Company granted nonqualified stock options to the following executive officers to each acquire 500,000 shares of the Company’s common stock: Richard MacPherson (President and Chief Executive Officer), John Pavlish (Senior Vice President and Chief Technology Officer) and James Trettel (Vice President of Operations); and, also granted nonqualified stock options to the following persons to each acquire 250,000 shares of the Company’s common stock: Christopher Greenberg (Chairman of the Board) and David M. Kaye (director). | ||||||||||
| January 1, 2020 [Member] | ||||||||||||
| Common stock shares issued for services | 1,000,000 | |||||||||||
| Stock Issued During Period, Value | $ 200,000 | |||||||||||
| Frederick Van Zijl [Member] | ||||||||||||
| Compensation Included included in selling, general and administrative expenses | $ 63,500 | |||||||||||
| Common stock shares issued for services | 235,184 | |||||||||||
| Allan T. Grantham [Member] | ||||||||||||
| Compensation Included included in selling, general and administrative expenses | $ 55,040 | |||||||||||
| Common stock shares issued for services | 229,333 | |||||||||||
| Non affiliated Third Party [Member] | October 5, 2020 [Member] | ||||||||||||
| Common stock shares issued | 300,000 | |||||||||||
| Common stock shares issued, amount | $ 102,000 | |||||||||||
| Intrinsic Value [Member] | ||||||||||||
| Exercise price | $ 0.17 | |||||||||||
| Stock option, shares | 1,500 | |||||||||||
| Common stock shares issued | 1,082 | |||||||||||
| Market value per share | $ 0.61 | |||||||||||
| 2014 Equity Plan [Member] | ||||||||||||
| common stock aggregate acquire shares | 4,675,000 | |||||||||||
| Extension of certain stock option expiration | $ 745,989 | |||||||||||
| Debt conversion description | The extended options are exercisable from $0.42 to $1.36 per share, representing the original fair market value of the common stock on the date of grant as determined under the 2014 Equity Plan | |||||||||||